Pro Medicus Limited (AU:PME) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Pro Medicus Limited has reported a stellar financial year, marked by a 29.3% increase in revenue and a 36.5% rise in net profit after tax. The company’s success is attributed to its innovative technology, skilled management, and strategic contract wins, including its largest contract in North America with Baylor Scott & White. With a strong pipeline and strategic investments, Pro Medicus is poised for continued growth in the competitive market.
For further insights into AU:PME stock, check out TipRanks’ Stock Analysis page.
